EUCTR2008-001501-42-FI进行中（未招募）不适用
Tacrolimus in the treatment of Painful Bladder Syndrome / Interstitial Cystitis
Jukka Sairanen0 个研究点开始时间: 2008年3月18日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Treatment of Bladder Pain Syndrome with Onabotulinum toxin ABladder Pain SyndromeMedDRA version: 20.0Level: LLTClassification code 10071166Term: Bladder pain syndromeSystem Organ Class: 100000004857EUCTR2014-001013-81-PTCentro Hospitalar de São João, EPE30
已完成
3 期
Efficacy of clorpactin('registered trademark (R)) in bladder pain syndrome/interstitial cystitis: a randomised placebo-controlled trialBladder pain syndrome/interstitial cystitisRenal and Urogenital - Other renal and urogenital disordersACTRN12611000717954Mercy Hospital for Women54
终止
2 期
Low-dose Naltrexone for Bladder Pain SyndromeBladder Pain SyndromeInterstitial CystitisNCT04450316Stanford University29
已完成
4 期
Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in ChildrenNephrotic SyndromeNCT01162005Seoul National University Hospital77
已完成
2 期
Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.Overactive BladderNCT00231491Assistance Publique - Hôpitaux de Paris160